Ischemic Heart Disease Worldwide, 1990 to 2013
2015; Lippincott Williams & Wilkins; Volume: 8; Issue: 4 Linguagem: Inglês
10.1161/circoutcomes.115.002007
ISSN1941-7705
AutoresDawn Shepard, Amelia VanderZanden, Andrew E. Moran, Mohsen Naghavi, Christopher J L Murray, Gregory A. Roth,
Tópico(s)Healthcare Policy and Management
ResumoHomeCirculation: Cardiovascular Quality and OutcomesVol. 8, No. 4Ischemic Heart Disease Worldwide, 1990 to 2013 Free AccessResearch ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessResearch ArticlePDF/EPUBIschemic Heart Disease Worldwide, 1990 to 2013Estimates From the Global Burden of Disease Study 2013 Dawn Shepard, BA, Amelia VanderZanden, MSc, Andrew Moran, MD, MPH, Mohsen Naghavi, MD, PhD, Christopher Murray, MD, DPhil and Gregory Roth, MD, MPH Dawn ShepardDawn Shepard From the Institute for Health Metrics and Evaluation (D.S., A.V., M.N., C.M., G.R.) and Division of General Medicine, Columbia University Medical Center (A.M.), University of Washington, Seattle. Search for more papers by this author , Amelia VanderZandenAmelia VanderZanden From the Institute for Health Metrics and Evaluation (D.S., A.V., M.N., C.M., G.R.) and Division of General Medicine, Columbia University Medical Center (A.M.), University of Washington, Seattle. Search for more papers by this author , Andrew MoranAndrew Moran From the Institute for Health Metrics and Evaluation (D.S., A.V., M.N., C.M., G.R.) and Division of General Medicine, Columbia University Medical Center (A.M.), University of Washington, Seattle. Search for more papers by this author , Mohsen NaghaviMohsen Naghavi From the Institute for Health Metrics and Evaluation (D.S., A.V., M.N., C.M., G.R.) and Division of General Medicine, Columbia University Medical Center (A.M.), University of Washington, Seattle. Search for more papers by this author , Christopher MurrayChristopher Murray From the Institute for Health Metrics and Evaluation (D.S., A.V., M.N., C.M., G.R.) and Division of General Medicine, Columbia University Medical Center (A.M.), University of Washington, Seattle. Search for more papers by this author and Gregory RothGregory Roth From the Institute for Health Metrics and Evaluation (D.S., A.V., M.N., C.M., G.R.) and Division of General Medicine, Columbia University Medical Center (A.M.), University of Washington, Seattle. Search for more papers by this author Originally published1 Jul 2015https://doi.org/10.1161/CIRCOUTCOMES.115.002007Circulation: Cardiovascular Quality and Outcomes. 2015;8:455–456Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: January 1, 2015: Previous Version 1 Ischemic heart disease (IHD) was responsible for 8.1 million deaths in 2013 (95% uncertainty interval, 7.3–8.8 million), the most recent year estimated, which was 14.8% of deaths worldwide (95% uncertainty interval, 13.4%–15.8%). IHD was the leading cause of death globally among men and women in both 1990 and 2013. In 2013, it was responsible for nearly half of all deaths from cardiovascular disease, causing as many deaths as chronic obstructive pulmonary disease, diabetes mellitus, cirrhosis, lung cancer, and liver cancer combined. There was an increase of 42% (95% uncertainty interval, 36%–48%) in the number of IHD deaths since 1990. The number of men dying from IHD was consistently higher than the number of women during this time period, and there was a larger relative increase in IHD deaths among men than among women. However, IHD is responsible for a slightly higher percentage of deaths among women than among men (15.3% versus 14.4%) because of significantly more IHD deaths among women aged ≥80 years.The countries reporting the highest age-standardized rates of IHD mortality are primarily in Central Asia and Eastern Europe, but countries in South Asia have seen substantial increases in age-standardized IHD mortality rates during the past 2 decades. In marked contrast, high-income countries have reported sharp decreases in age-standardized mortality rates. High-income regions saw decline in mortality rates by as much as ≥50% between 1990 and 2013 and now account for some of the lowest IHD mortality rates in the world. Age-standardized death rates are also lower in most of sub-Saharan Africa; however, much of this region saw one of the highest relative increases in age-standardized mortality between 1990 and 2013. At the country level, the upper and lower extremes of IHD mortality rates vary by an order of magnitude: in Belarus, age-standardized mortality rates among men exceeded 600 per 100 000 in 2013; however, women in Japan had a mortality rate of 31 per 100 000 in 2013.MethodThe Global Burden of Disease Study 2013 produced consistent measures of death by age and sex for 188 countries for the years 1990 to 2013 for 240 causes of death. Detailed methods and results have been reported.1 Briefly, all available data on mortality were collected, including data from vital registration and verbal autopsy. Nonspecific conditions reported as underlying causes of death were redistributed using statistical methods or expert opinion. Versions of death coding were mapped to a uniform system. Ensemble modeling was used to estimate cause-specific mortality using death data and country-level covariates. Out-of-sample validity testing was performed for each cause-specific model, and uncertainty was estimated by taking 1000 draws from the posterior distribution of the ensemble model, with point estimates taken as the median value. Cause-specific death was adjusted to fit the envelope of global all-cause mortality. In this visualization, we restricted country-level estimates to those countries which produce vital registration or verbal autopsy data. The Figure is created with Adobe Illustrator.Download figureDownload PowerPointFigure. Ischemic heart disease (IHD) worldwide, 1990 to 2013, from the Global Burden of Disease Study (GBD) 2013. Source: Institute for Health Metrics and Evaluation.Sources of FundingThis study was supported by the Bill and Melinda Gates Foundation.DisclosuresNone.FootnotesCorrespondence to Gregory Roth, MD, MPH, Institute for Health Metrics and Evaluation, University of Washington, 2301 5th Ave, Suite 600, Seattle, WA 98121. E-mail [email protected]References1. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013.Lancet. 2015; 385:117–171.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Chibisov S, Kharlitskaya E, Singh R, Itharat A, On-Saard E, Park H, Chaudhury J, Chakravorty S, Gupta O and Smail M (2022) Polyphenolics and flavonoids in health and diseases Functional Foods and Nutraceuticals in Metabolic and Non-Communicable Diseases, 10.1016/B978-0-12-819815-5.00016-1, (671-689), . Zhang G, Ding L, Sun G, Liu Z, Ou W, Wang B and Sun Y (2022) LncRNA AZIN1-AS1 ameliorates myocardial ischemia–reperfusion injury by targeting miR-6838-5p/WNT3A axis to activate Wnt-β/catenin signaling pathway, In Vitro Cellular & Developmental Biology - Animal, 10.1007/s11626-022-00646-1, 58:1, (54-68), Online publication date: 1-Jan-2022. Chen M, Liu D, Weidemann F, Lengenfelder B, Ertl G, Hu K, Frantz S and Nordbeck P (2021) Echocardiographic risk factors of left ventricular thrombus in patients with acute anterior myocardial infarction, ESC Heart Failure, 10.1002/ehf2.13605, 8:6, (5248-5258), Online publication date: 1-Dec-2021. Allen A, Gau D and Roy P (2021) The role of profilin-1 in cardiovascular diseases, Journal of Cell Science, 10.1242/jcs.249060, 134:9, Online publication date: 1-May-2021. Feitosa G (2021)(2021) Mortality from Cardiovascular Disease in Bahia, International Journal of Cardiovascular Sciences, 10.36660/ijcs.20200374, Online publication date: 16-Apr-2021., Online publication date: 16-Apr-2021. Etli M (2020) Investigation of serum ischemia-modified albumin levels in coronary artery disease patients, Indian Journal of Thoracic and Cardiovascular Surgery, 10.1007/s12055-020-01061-5, 37:2, (147-152), Online publication date: 1-Mar-2021. Wang X, Yu Y, Yu C, Shi F and Zhang Y (2020) Associations between acute exposure to ambient air pollution and length of stay for inpatients with ischemic heart disease: a multi-city analysis in central China, Environmental Science and Pollution Research, 10.1007/s11356-020-10256-7, 27:35, (43743-43754), Online publication date: 1-Dec-2020. Mukhtar S (2020) Are individuals with cardiovascular disease at risk of COVID-19-related mental health problems or individuals with cardiovascular disease at risk of cardiovascular disease-related mental health problems during COVID-19? A psychological-psychiatric perspective, Medical Hypotheses, 10.1016/j.mehy.2020.109919, 144, (109919), Online publication date: 1-Nov-2020. Ren P, Zhang M and Dai S Therapeutic effects of coronary granulocyte colony-stimulating factor on rats with chronic ischemic heart disease, Open Life Sciences, 10.1515/biol-2020-0078, 15:1, (742-752) Zhu H, Xi Y, Bao H, Xu X, Niu L, Tao Y, Cao N, Wang W and Zhang X (2020) Assessment of cardiovascular disease risk in Northern China: a cross-sectional study, Annals of Human Biology, 10.1080/03014460.2020.1779814, 47:5, (498-503), Online publication date: 3-Jul-2020. Niu X, Pu S, Ling C, Xu J, Wang J, Sun S, Yao Y and Zhang Z (2020) lncRNA Oip5‐as1 attenuates myocardial ischaemia/reperfusion injury by sponging miR‐29a to activate the SIRT1/AMPK/PGC1α pathway, Cell Proliferation, 10.1111/cpr.12818, 53:6, Online publication date: 1-Jun-2020. Buljubasic N, Zhao W, Cheng J, Li H, Oemrawsingh R, Akkerhuis M, Yu H, Zhou L, Wu Y, Boersma E and Gao W (2020) Comparison of temporal changes in established cardiovascular biomarkers after acute coronary syndrome between Caucasian and Chinese patients with diabetes mellitus, Biomarkers, 10.1080/1354750X.2020.1759692, 25:4, (341-348), Online publication date: 18-May-2020. Deschênes S, Burns R and Schmitz N (2020) Anxiety and Depression Symptom Comorbidity and the Risk of Heart Disease: A Prospective Community-Based Cohort Study, Psychosomatic Medicine, 10.1097/PSY.0000000000000790, 82:3, (296-304), Online publication date: 1-Apr-2020. Ferraris V and Pezzella A (2020) Commentary: Worldwide disparities in cardiac surgical care: Thinking globally not locally to solve problems of limited resources and access to specialized care, The Journal of Thoracic and Cardiovascular Surgery, 10.1016/j.jtcvs.2019.04.070, 159:3, (997-999), Online publication date: 1-Mar-2020. Qiu Q, Shen T, Wang Q, Yu X, Jia N and He Q (2019) Cardiac shock wave therapy protects cardiomyocytes from hypoxia‑induced injury by modulating miR‑210, Molecular Medicine Reports, 10.3892/mmr.2019.10892 Li D, Hu L, Liang Q, Zhang C, Shi Y, Wang B and Wang K (2019) Peripheral T cell receptor beta immune repertoire is promptly reconstituted after acute myocardial infarction, Journal of Translational Medicine, 10.1186/s12967-019-1788-4, 17:1, Online publication date: 1-Dec-2019. Henrich S, Hong B, Rink J, Nguyen S and Thaxton C (2019) Supramolecular Assembly of High-Density Lipoprotein Mimetic Nanoparticles Using Lipid-Conjugated Core Scaffolds, Journal of the American Chemical Society, 10.1021/jacs.9b00651, 141:25, (9753-9757), Online publication date: 26-Jun-2019. Shapovalova E, Maksimov S and Artamonova G (2019) Gender differences of cardiovascular risk, Russian Journal of Cardiology, 10.15829/1560-4071-2019-4-99-104:4, (99-104) Passaglia L, Brant L, Nascimento B and Ribeiro A (2019) Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS), Medicine, 10.1097/MD.0000000000015681, 98:22, (e15681), Online publication date: 1-May-2019. Nozari Y, Geraiely B, Alipasandi K, Jalali A, Omidi N, Aghajani H, Hajizeinali A, Alidoosti M, Pourhoseini H, Salarifar M, Amirzadegan A, Nematipour E and Nomali M (2019) Time to Treatment and In-Hospital Major Adverse Cardiac Events Among Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention (PCI) According to the 24/7 Primary PCI Service Registry in Iran: Protocol for a Cross-Sectional Study, JMIR Research Protocols, 10.2196/13161, 8:3, (e13161) Wan X, Ren H, Ma E and Yang G (2017) Mortality trends for ischemic heart disease in China: an analysis of 102 continuous disease surveillance points from 1991 to 2009, BMC Public Health, 10.1186/s12889-017-4558-3, 18:1, Online publication date: 1-Dec-2018. Piplani S, Alemao N, Prabhu M, Ambar S, Chugh Y and Chugh S (2018) Correlation of the telomere length with type 2 diabetes mellitus in patients with ischemic heart disease, Indian Heart Journal, 10.1016/j.ihj.2018.09.007, 70, (S173-S176), Online publication date: 1-Dec-2018. Tu C and Zoldan J (2018) Moving iPSC-Derived Cardiomyocytes Forward to Treat Myocardial Infarction, Cell Stem Cell, 10.1016/j.stem.2018.08.011, 23:3, (322-323), Online publication date: 1-Sep-2018. Manickam M, Boggu P, Pillaiyar T, Sharma N, Jalani H, Venkateswararao E and Jung S (2018) Exploration of diphenylalkyloxadiazoles as novel cardiac myosin activator, Bioorganic & Medicinal Chemistry Letters, 10.1016/j.bmcl.2018.06.031, 28:14, (2369-2374), Online publication date: 1-Aug-2018. Smenes B, Bækkerud F, Slagsvold K, Hassel E, Wohlwend M, Pinho M, Høydal M, Wisløff U, Rognmo Ø and Wahba A (2018) Acute exercise is not cardioprotective and may induce apoptotic signalling in heart surgery: a randomized controlled trial†, Interactive CardioVascular and Thoracic Surgery, 10.1093/icvts/ivx439, 27:1, (95-101), Online publication date: 1-Jul-2018. De Hert M, Detraux J and Vancampfort D (2022) The intriguing relationship between coronary heart disease and mental disorders, Dialogues in Clinical Neuroscience, 10.31887/DCNS.2018.20.1/mdehert, 20:1, (31-40), Online publication date: 31-Mar-2018. Wacker B, Dronadula N, Bi L, Stamatikos A and Dichek D (2017) Apo A-I (Apolipoprotein A-I) Vascular Gene Therapy Provides Durable Protection Against Atherosclerosis in Hyperlipidemic Rabbits, Arteriosclerosis, Thrombosis, and Vascular Biology, 38:1, (206-217), Online publication date: 1-Jan-2018. Narita H, Shima F, Yokoyama J, Miyagawa S, Tsukamoto Y, Takamura Y, Hiura A, Fukumoto K, Chiba T, Watanabe S, Sawa Y, Akashi M and Shimoda H (2017) Engraftment and morphological development of vascularized human iPS cell-derived 3D-cardiomyocyte tissue after xenotransplantation, Scientific Reports, 10.1038/s41598-017-14053-0, 7:1, Online publication date: 1-Dec-2017. Savoia C, Volpe M, Grassi G, Borghi C, Agabiti Rosei E and Touyz R (2017) Personalized medicine—a modern approach for the diagnosis and management of hypertension, Clinical Science, 10.1042/CS20160407, 131:22, (2671-2685), Online publication date: 15-Nov-2017. Deng X, Xing X, Sun G, Xu X, Wu H, Li G and Sun X (2017) Guanxin Danshen Formulation Protects against Myocardial Ischemia Reperfusion Injury-Induced Left Ventricular Remodeling by Upregulating Estrogen Receptor β, Frontiers in Pharmacology, 10.3389/fphar.2017.00777, 8 Nallamothu B (2017) Global Health and Circulation: Cardiovascular Quality & Outcomes, Circulation: Cardiovascular Quality and Outcomes, 10:11, Online publication date: 1-Nov-2017.Jardim T, Reiger S, Abrahams-Gessel S, Crowther N, Wade A, Gómez-Olivé F, Salomon J, Tollman S and Gaziano T (2017) Disparities in Management of Cardiovascular Disease in Rural South Africa, Circulation: Cardiovascular Quality and Outcomes, 10:11, Online publication date: 1-Nov-2017. Thomas B, Matsushita K, Abate K, Al-Aly Z, Ärnlöv J, Asayama K, Atkins R, Badawi A, Ballew S, Banerjee A, Barregård L, Barrett-Connor E, Basu S, Bello A, Bensenor I, Bergstrom J, Bikbov B, Blosser C, Brenner H, Carrero J, Chadban S, Cirillo M, Cortinovis M, Courville K, Dandona L, Dandona R, Estep K, Fernandes J, Fischer F, Fox C, Gansevoort R, Gona P, Gutierrez O, Hamidi S, Hanson S, Himmelfarb J, Jassal S, Jee S, Jha V, Jimenez-Corona A, Jonas J, Kengne A, Khader Y, Khang Y, Kim Y, Klein B, Klein R, Kokubo Y, Kolte D, Lee K, Levey A, Li Y, Lotufo P, El Razek H, Mendoza W, Metoki H, Mok Y, Muraki I, Muntner P, Noda H, Ohkubo T, Ortiz A, Perico N, Polkinghorne K, Al-Radaddi R, Remuzzi G, Roth G, Rothenbacher D, Satoh M, Saum K, Sawhney M, Schöttker B, Shankar A, Shlipak M, Silva D, Toyoshima H, Ukwaja K, Umesawa M, Vollset S, Warnock D, Werdecker A, Yamagishi K, Yano Y, Yonemoto N, Zaki M, Naghavi M, Forouzanfar M, Murray C, Coresh J and Vos T (2017) Global Cardiovascular and Renal Outcomes of Reduced GFR, Journal of the American Society of Nephrology, 10.1681/ASN.2016050562, 28:7, (2167-2179), Online publication date: 1-Jul-2017. Manickam M, Jalani H, Pillaiyar T, Sharma N, Boggu P, Venkateswararao E, Lee Y, Jeon E and Jung S (2017) Exploration of flexible phenylpropylurea scaffold as novel cardiac myosin activators for the treatment of systolic heart failure, European Journal of Medicinal Chemistry, 10.1016/j.ejmech.2017.04.005, 134, (379-391), Online publication date: 1-Jul-2017. Tan J, Lam C, Kasim S, Aw T, Abanilla J, Chang W, Dang V, Iboleon-Dy M, Mumpuni S, Phommintikul A, Ta M, Topipat P, Yiu K and Cullen L (2017) Asia-Pacific consensus statement on the optimal use of high-sensitivity troponin assays in acute coronary syndromes diagnosis: focus on hs-TnI, Heart Asia, 10.1136/heartasia-2016-010818, 9:1, (81-87), Online publication date: 1-Apr-2017. Yang G, Weng X, Zhao Y, Zhang X, Hu Y, Dai X, Liang P, Wang P, Ma L, Sun X, Hou L, Xu H, Fang M, Li Y, Jenuwein T, Xu Y and Sun A (2017) The histone H3K9 methyltransferase SUV39H links SIRT1 repression to myocardial infarction, Nature Communications, 10.1038/ncomms14941, 8:1, Online publication date: 1-Apr-2017. Gupta R, Kaur M, Islam S, Mohan V, Mony P, Kumar R, Kutty V, Iqbal R, Rahman O, Deepa M, Antony J, Vijaykumar K, Kazmi K, Yusuf R, Mohan I, Panwar R, Rangarajan S and Yusuf S (2017) Association of Household Wealth Index, Educational Status, and Social Capital with Hypertension Awareness, Treatment, and Control in South Asia, American Journal of Hypertension, 10.1093/ajh/hpw169, (hpw169) Chang J, Li B, Li J and Sun Y (2017) The Effects of Age, Period, and Cohort on Mortality from Ischemic Heart Disease in China, International Journal of Environmental Research and Public Health, 10.3390/ijerph14010050, 14:1, (50) Maas A and Bairey Merz C (2017) Female Manifestation of Acute Coronary Syndromes Manual of Gynecardiology, 10.1007/978-3-319-54960-6_3, (55-76), . van Berlo J, Garry M and Garry D (2017) Regenerative Mechanisms of the Adult Injured and Failing Heart Congestive Heart Failure and Cardiac Transplantation, 10.1007/978-3-319-44577-9_23, (377-400), . Li G, Zeng Q and Pan X (2016) Disease burden of ischaemic heart disease from short-term outdoor air pollution exposure in Tianjin, 2002–2006, European Journal of Preventive Cardiology, 10.1177/2047487316651352, 23:16, (1774-1782), Online publication date: 1-Nov-2016. Antman E and Loscalzo J (2016) Precision medicine in cardiology, Nature Reviews Cardiology, 10.1038/nrcardio.2016.101, 13:10, (591-602), Online publication date: 1-Oct-2016. Krumholz H (2016) The Privilege of Editorship, Circulation: Cardiovascular Quality and Outcomes, 9:5, (489-494), Online publication date: 1-Sep-2016. Weng S, Li X, Niu M, Ge B and Yu H (2016) Blu-ray Technology-Based Quantitative Assays for Cardiac Markers: From Disc Activation to Multiplex Detection, Analytical Chemistry, 10.1021/acs.analchem.6b01604, 88:13, (6889-6896), Online publication date: 5-Jul-2016. Banerjee A (2016) Stable coronary disease: Cinderella must go to the ball, European Heart Journal - Quality of Care and Clinical Outcomes, 10.1093/ehjqcco/qcw022, 2:3, (151-152), Online publication date: 1-Jul-2016. Xie X, Zhou W, Lin F, Li X, Zhong W, Lin S, Li W, Chen T, Ye Y, Hu X, Lin X, Huang S, Lin X, Yu X and Fang X (2016) Ischemic heart disease deaths, disability-adjusted life years and risk factors in Fujian, China during 1990–2013: Data from the Global Burden of Disease Study 2013, International Journal of Cardiology, 10.1016/j.ijcard.2016.03.236, 214, (265-269), Online publication date: 1-Jul-2016. Lee S, Lee S, Choi E, Ham O, Lee C, Lee J, Seo H, Cha M, Mun B, Lee Y, Yoon C and Hwang K (2016) Small molecule-mediated up-regulation of microRNA targeting a key cell death modulator BNIP3 improves cardiac function following ischemic injury, Scientific Reports, 10.1038/srep23472, 6:1, Online publication date: 31-Mar-2016. Lee Y, Yoon S, Kim A, Seo H and Ko S (2016) Health Performance and Challenges in Korea: a Review of the Global Burden of Disease Study 2013, Journal of Korean Medical Science, 10.3346/jkms.2016.31.S2.S114, 31:Suppl 2, (S114) July 2015Vol 8, Issue 4 Advertisement Article InformationMetrics © 2015 American Heart Association, Inc.https://doi.org/10.1161/CIRCOUTCOMES.115.002007PMID: 26152681 Originally publishedJuly 1, 2015 Keywordsmyocardial ischemiadeathpopulationmortalitycause of deathPDF download Advertisement SubjectsEthics and Policy
Referência(s)